▲ 0.94%
prev close
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
Congressional Trades
1
All tracked trades
Members Trading
1
Unique members
Net Activity
+1
1 buys · 0 sells
Members Who Traded This Stock
1 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2023-12-05 | BNTXBioNTech SE - American Depositary Shares | Buy | $1,001 - $15,000 | 832d ago | — |
2023-12-05
Josh Gottheimer
BNTX
Amount
$1,001 - $15,000
Filed
832d ago
Recent News
Powered by Polygon.io
Non-Small Cell Lung Cancer Clinical Trial Race Intensifies as 100+ Companies Competing in Therapeutic Segment Worldwide | DelveInsight
Anaveon appoints Biotech Leader Thaminda Ramanayake as Chief Executive Officer
BioNTech Stock Tanks As Outlook, Founder Exit Rattle Bulls
BioNTech SE Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
BioNTech Stock Tumbles As Co-Founders Pivot To New MRNA Venture
Trade Timeline
Congressional activity, newest first
Josh Gottheimer
2023-12-05 · Purchase
$1,001 - $15,000